Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Caredx Inc (NQ: CDNA )

15.28 +0.08 (+0.53%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 443,458
Open 15.17
Bid (Size) 15.28 (1)
Ask (Size) 16.80 (1)
Prev. Close 15.20
Today's Range 15.08 - 15.42
52wk Range 10.50 - 46.88
Shares Outstanding 52,627,165
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
The growth-focused money manager is making moves. 
Via The Motley Fool
JACC Publication Guides Use of CareDx’s HeartCare Transplant Rejection Surveillance in Clinical Practice
From CareDx, Inc.
Via Business Wire

Performance

YTD
+37.66%
+37.66%
1 Month
+33.80%
+33.80%
3 Month
-23.25%
-23.25%
6 Month
-34.48%
-34.48%
1 Year
-60.32%
-60.32%

More News

Read More
CareDx Fosters Transplant Innovation as Distinguished Founder’s Circle Sponsor for the 23rd Annual American Society of Transplant Surgeons State of the Art Winter Symposium
From CareDx, Inc.
Via Business Wire
CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2022
From CareDx, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Don’t Put CareDX Stock in Your Portfolio’s Pipeline
Via InvestorPlace
CAREDX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CareDx, Inc. - CDNA
From Kahn Swick & Foti, LLC
Via Business Wire
New ISHLT Guidelines Support Use of CareDx’s HeartCare Solutions, AlloMap and AlloSure, in Routine Monitoring of Heart Transplant Patients
From CareDx, Inc.
Via Business Wire
CareDx Announces $50 Million Stock Repurchase Program
From CareDx, Inc.
Via Business Wire
CAREDX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CareDx, Inc. - CDNA
From Kahn Swick & Foti, LLC
Via Business Wire
Independent Prospective Study Defines Reference Range for CareDx’s AlloSure for Long-Term Lung Transplant Surveillance
From CareDx, Inc.
Via Business Wire
CareDx Committed to Delivering Clinical Innovation to the Transplant Patient and Physician Community
From CareDx, Inc.
Via Business Wire
Yelp, Twilio, Atlassian, And Other Big Losers From Friday
Via Benzinga
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
Via Benzinga
Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
CareDx To Participate in Upcoming Investor Conferences
From CareDx, Inc.
Via Business Wire
CareDx Reports Third Quarter 2022 Results
From CareDx, Inc.
Via Business Wire
CareDx Demonstrates Power of AlloSure and Digital Health Transplant Solutions at American Society of Nephrology Kidney Week
From CareDx, Inc.
Via Business Wire
Independent Longitudinal Study Finds CareDx’s AlloSure Detects Early Signs of Rejection in Pediatric Kidney Transplant Patients
From CareDx, Inc.
Via Business Wire
CareDx Congratulates C-Path's Transplant Therapeutics Consortium and Paris Transplant Group for Receiving EMA Draft Qualification for iBox Scoring System
From CareDx, Inc.
Via Business Wire
CareDx to Report Third Quarter 2022 Financial Results
From CareDx, Inc.
Via Business Wire
CareDx Joins Forces with National Kidney Foundation and Honor the Gift Coalition to Host Immuno Bill Webinar for Kidney Transplant Patients
From CareDx, Inc.
Via Business Wire
CareDx Presents Latest Data on AlloSeq NGS Solutions and Transplant Innovation at the American Society for Histocompatibility and Immunogenetics Annual Meeting
From CareDx, Inc.
Via Business Wire
5 Top Stocks Cathie Wood Is Buying This Week
Via InvestorPlace
CareDx to Host Symposium Covering Innovation in Multimodal Surveillance Including AiCAV for Post-Cardiac Transplant Care
From CareDx, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.